Akums combines two potent diabetes medicines for enhanced treatment efficacy
Akums Drugs & Pharmaceuticals has launched Dapagliflozin + Pioglitazone tablets, a dual-action therapy for diabetes management
Akums Drugs & Pharmaceuticals has launched Dapagliflozin + Pioglitazone tablets, a dual-action therapy for diabetes management
Dyrupeg will be available as 6 mg solution for injection in prefilled syringe and is intended for the reduction in the duration of neutropenia
The session focused on “Biomanufacturing of Enzymes,” a critical domain under the BioE3 Policy.
The technical program will run in four sessions and a panel discussion on “Challenges in translation of medical technologies”
Acquisition to advance company's next generation biology portfolio with internationally recognized pioneer in organoid development
CLL is one of the most common leukemias among adults affecting more than 200,000 people in the US
IMKELDI is an advanced liquid formulation of imatinib designed to provide dosing accuracy
This partnership is set to meet the growing demand for innovative life science research solutions in the Vietnamese market
Aromatic L-amino acid decarboxylase deficiency is a rare genetic disorder that affects the production of some neurotransmitters
Subscribe To Our Newsletter & Stay Updated